4BIO Capital leads EUR 40 million seed round for Aptadir Therapeutics
4BIO Capital led a EUR 40 million seed financing in Aptadir Therapeutics to advance its RNA medicines pipeline, with EXTEND also participating.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.